Hepatocellular carcinoma in hispanics

El-Serag, 2007, Epidemiology of hepatocellular carcinoma in hispanics in the United States, Arch Intern Med, 167, 1983, 10.1001/archinte.167.18.1983

Sistema Nacional de Información en Salud (SINAIS). [Main causes of general mortality 2005]. http://sinais.salud.gob.mx/mortalidad/mortalidad.htm.

Mendez-Sanchez, 2005, Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data, Ann Hepatol, 4, 52, 10.1016/S1665-2681(19)32086-1

Powell, 2005, Steatosis: co-factor in other liver diseases, Hepatology, 42, 5, 10.1002/hep.20750

Mendez-Sanchez, 2004, The relationship of overweight and obesity to high mortality rates from liver cirrhosis in Mexico, Ann Hepatol, 3, 66, 10.1016/S1665-2681(19)32111-8

Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States, Hepatology, 36, 1349, 10.1002/hep.1840360609

Browning, 2004, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466

Schulz, 2007, Effects of traditional and western, Arch Intern Med, 167, 1983

2007, Plenary top 5, Oncology, 21, 896